Cite
Kuca K, Cabal J, Jun D, et al. In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases. Toxicol Mech Methods. 2008;18(4):329-33doi: 10.1080/15376510701380323.
Kuca, K., Cabal, J., Jun, D., & Koleckar, V. (2008). In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases. Toxicology mechanisms and methods, 18(4), 329-33. https://doi.org/10.1080/15376510701380323
Kuca, Kamil, et al. "In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases." Toxicology mechanisms and methods vol. 18,4 (2008): 329-33. doi: https://doi.org/10.1080/15376510701380323
Kuca K, Cabal J, Jun D, Koleckar V. In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases. Toxicol Mech Methods. 2008;18(4):329-33. doi: 10.1080/15376510701380323. PMID: 20020898.
Copy
Download .nbib